Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2.
- Author:
Long CHEN
1
;
Guo-qing ZUO
;
Jin-feng WU
;
Gui-li ZENG
;
Tao LI
;
Zuo-jin LIU
;
Kai-fu TANG
Author Information
- Publication Type:Journal Article
- MeSH: ATP-Binding Cassette, Sub-Family B, Member 1; genetics; metabolism; Carcinoma, Hepatocellular; genetics; metabolism; pathology; Coculture Techniques; methods; Doxorubicin; pharmacology; Drug Resistance, Multiple; Drug Resistance, Neoplasm; genetics; Genes, MDR; Green Fluorescent Proteins; Hep G2 Cells; Humans; Liver Neoplasms; genetics; metabolism; pathology; Plasmids; Protein Transport; RNA, Messenger; genetics; metabolism; Transfection
- From: Chinese Journal of Hepatology 2009;17(11):839-842
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate whether there is intercellular transfer of functional P-glycoprotein(P-gp) from P-gp-positive cells to P-gp-negative cells in vitro.
METHODSHepG2/GFP cells, a HepG2 cell line stably expressing GFP, were co-cultured with HepG2/ADM cells, an adriamycin-resistant cell line derived from HepG2 cells. The distribution of P-gp in hepatocellular carcinoma cell was observed under laser scanning confocal microscope (LSCM). Immunomagnetic beads were used to separate HepG2/GFP cells from the mixed culture. The abundance of P-gp was analyzed by western blot, and the expression of mdr1 mRNA was detected by qRT-PCR.
RESULTSYellow fluorescence was detected in HepG2/aqMDR cells, green fluorescence was detected in HepG2/GFP cells, red fluorescence was detected in HepG2/ADM cells by LSCM. The level of P-gp protein in HepG2/aqMDR cells was lower than that in HepG2/ADM cells, but higher than that in HepG2/GFP cells (q = 35.07, P < 0.05) and HepG2 cells (q = 36.87, P < 0.05). The expression of mdr1 mRNA in HepG2/ADM cells was higher than that in HepG2/aqMDR, HepG2 and HepG2/GFP cells, but there was no significant difference in mdr1 mRNA among HepG2/aqMDR, HepG2 and HepG2/GFP cells (F = 2.30, P > 0.05).
CONCLUSIONSP-gp can transfer from drug resistant hepatocellular cells to sensitive hepatocellular carcinoma cells. This study suggests a novel mechanism of multidrug resistance in hepatocellular carcinoma.